Examples of Novel vaccine in a sentence
Novel vaccine and probiotic treatments that will prevent infections from Enterobacteriaceae, e.g.E. coli, Salmonella and mitigate antibiotic resistance.
Novel vaccine developmental work is looking to take advantage of antigens present on virulent M.
G.: Novel vaccine delivery system induces robust humoral and cellular immune responses based on multiple mechanisms.
Novel vaccine delivery methods such as microneedles can render vaccination easier and more acceptable to the public by simplifying vaccine access, and can confer equal or superior immunological responses to that induced by hypodermic needle through conventional intramuscular administration (Kim 2012).Microneedles are micron-scale needles that administer vaccine directly into the skin using a simple minimally invasive approach without generating sharps waste.
Novel vaccine development for DENV preventionIn humans, both CD4+ and CD8+ T cells contribute to protection against DENV with CD8+ T cells preferentially targeting non-structural proteins NS3, NS4B and NS5.
Novel vaccine technologies: essential components of an adequate response to emerging viral diseases.
Additionally, this vaccine is already approved, so the safe and immunogenic doses are already known.Applications• Vaccines for the prevention of rubella and other indications.• Use of rubella vector for expression of foreign genes.Advantages• Novel vaccine candidate• Rapid production timeDevelopment Status: Preclinical studies have been conducted by the inventors.Inventors: Ira Berkower and Angelo Spadaccini (FDA).
Novel vaccine regimens that were studied included DNA vectors expressing viral proteins to prime the immune response and a replication-defective recombinant adenovirus serotype 5 (rAd5) vector to boost responses (Robinson and Weinhold 2006).
Lukashevich, MD, PhD, DSci Professor of Pharmacology & Toxicology M.D., Minsk Medical Institute, Belaris (1973);Ph.D., Institute of Virology, Academy of Medical Science, Moscow Russia (1976); D.Sc., Institute of Virology, Academy of Medical Science, Moscow Russia (1987) Research Interests: Novel vaccine technologies (virus-like-particle vectors; reassortant vaccines, infectious DNA vaccination); molecular biology and pathogenesis of viral hemorrhagic fevers.
Novel vaccine approaches to problem (2), in combination with checkpoint modulators, can drive extremely high and sustained T cell responses in non-human primates.